India's Pharmaceutical Exports

Country Profile

Iceland

Iceland is a developing market for Indian pharmaceuticals — $6.45M in FY 2025–26, with 2.4× growth over the past decade. Medicine Ingredients accounts for 61% of shipments. The compound annual growth rate since FY2015 stands at 8.3%.

🇮🇸 $6.45M · 2.4× growth since FY2015 · 8.3% CAGR
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$6.45M
Exports FY2025–26 DGCIS
2.4×
Growth FY2015→2026
8.3%
CAGR FY2015→2026
61%
Medicine Ingredients Share
4
Product Categories Supplied
Iceland is a developing market for Indian pharmaceuticals — $6.45M in FY 2025–26, with 2.4× growth over the past decade. Medicine Ingredients accounts for 61% of shipments. The compound annual growth rate since FY2015 stands at 8.3%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicine Ingredients $3.90M (60.5%) Medicines $2.50M (38.8%) Traditional & Herbal $36K (0.6%) Surgical & Hospital Supplies $6K (0.1%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Iceland in the RBI overseas direct investment dataset (2011–2026).